[Emergency treatment of acute heart failure].
Werdan
K
K
Martin-Luther-Universität Halle-Wittenberg. karl.werdan@medizin.uni-halle.de
D000208:Acute Disease; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000701:Analgesics, Opioid / Q000008:administration & dosage; D015906:Angioplasty, Balloon, Coronary; D000803:Angiotensin I / Q000037:antagonists & inhibitors; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002301:Cardiac Glycosides / Q000627:therapeutic use; D017147:Defibrillators, Implantable; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use; D004630:Emergencies; D005665:Furosemide / Q000008:administration & dosage; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D009020:Morphine / Q000008:administration & dosage; D009203:Myocardial Infarction / Q000150:complications; D009566:Nitrates / Q000008:administration & dosage; D005996:Nitroglycerin / Q000008:administration & dosage; D010138:Pacemaker, Artificial; D011379:Prognosis; D011654:Pulmonary Edema / Q000188:drug therapy*; D012121:Respiration, Artificial; D012307:Risk Factors; D012770:Shock, Cardiogenic / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage; D018497:Ventricular Dysfunction, Right / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D000701:Analgesics, Opioid; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002301:Cardiac Glycosides; D004232:Diuretics; D009566:Nitrates; D014665:Vasodilator Agents; D009020:Morphine; D005665:Furosemide; D000803:Angiotensin I; D005996:Nitroglycerin